ProCE Banner Activity

Clinical Resource: Toxicity Management Guide for Erdafitinib and Enfortumab Vedotin in Treatment of Urothelial Carcinoma

PDF
Download this PDF clinical resource on toxicity management to help optimize the care of your patients with progressive urothelial carcinoma receiving erdafitinib or enfortumab vedotin.

Released: November 05, 2020

Expiration: November 04, 2021

Share

Faculty

Kinjal Patel

Kinjal Patel, PharmD, BCOP

Clinical Oncology Pharmacist
Department of Oncology
Fox Chase Cancer Center
Philadelphia, Pennsylvania

Susan Roethke

Susan Roethke, CRNP, MSN, AOCN, ANP-BC

Nurse Practitioner
Department of Hematology/Oncology
Genitourinary Medical Oncology
Fox Chase Cancer Center
Temple Health
Philadelphia, Pennsylvania

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Astellas Seattle Genetics

Janssen administered by Scientific Affairs

Faculty Disclosure

Primary Author

Kinjal Patel, PharmD, BCOP

Clinical Oncology Pharmacist
Department of Oncology
Fox Chase Cancer Center
Philadelphia, Pennsylvania

Susan Roethke, CRNP, MSN, AOCN, ANP-BC

Nurse Practitioner
Department of Hematology/Oncology
Genitourinary Medical Oncology
Fox Chase Cancer Center
Temple Health
Philadelphia, Pennsylvania